Cellectis Announces Participation in Four Upcoming Investor Conferences in September
Published on September 01, 2022 in New York, NY
New York, NY – September 1, 2022 – Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that management plans to participate in four upcoming investor conferences.
Details for the events are below:
Citi's 17th Annual Biopharma Conference
Format: Panel
Date: September 7th, 2022
Time: 9:40AM- 10:25AM ET
Location: Four Seasons Hotel, Boston, MA
Webcast Link: http://www.veracast.com/webcasts/citigroup/biopharma2022/3DniPm.cfm
Wells Fargo 2022 Healthcare Conference
Format: Investor meetings
Date: September 7-9, 2022
Location: Encore Boston Harbor, Everett, MA
Baird Global Healthcare Conference
Format: Presentation
Date: September 13, 2022
Time: 10:15AM-10:45AM ET
Location: Intercontinental Barclay Hotel, New York City, NY
Jefferies Cell and Genetic Medicine Summit
Format: Presentation
Date: September 29, 2022
Time: Presentation time to be posted on Cellectis.com
Location: Palace Hotel, New York City, NY
Live webcasts and replays of these presentations will be available under the “Events and Webcasts” section on the Investor page of the of the Company’s website: https://cellectis.com/en/investors/events-and-webcasts/